Zentalis Pharmaceuticals Appoints Melissa Epperly as Chief Financial Officer

Zentalis Pharmaceuticals (the Company or Zentalis), a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics that target fundamental pathways in cancer, today announced the appointment of Melissa Epperly as Chief Financial Officer (CFO).